Cargando…

FIB-4 index serves as a noninvasive prognostic biomarker in patients with hepatocellular carcinoma: A meta-analysis

BACKGROUND: Liver fibrosis index FIB-4 has been reported to be linked with hepatocellular carcinoma (HCC) prognosis, but the results were not consistent. This study aimed to synthetically explore the relationship between FIB-4 and clinical outcomes of HCC. METHODS: A number of online databases were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yi, Wang, Rong, Yang, Xianjin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320186/ https://www.ncbi.nlm.nih.gov/pubmed/30572498 http://dx.doi.org/10.1097/MD.0000000000013696

Ejemplares similares

Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma
por: Kariyama, Kazuya, et al.
Publicado: (2019)

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

Prognostic value of aspartate aminotransferase to platelet ratio index as a noninvasive biomarker in patients with hepatocellular carcinoma: a meta-analysis
por: Zhang, Yi, et al.
Publicado: (2018)

Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis
por: Zhang, Yi, et al.
Publicado: (2018)

Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma
por: Cai, Zhixiong, et al.
Publicado: (2014)

CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
por: Zhou, Huifang, et al.
Publicado: (2019)

PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma
por: Jiang, Xiaocong, et al.
Publicado: (2021)

SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
por: Yoo, Wonbeak, et al.
Publicado: (2023)

EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis
por: Gu, Fangming, et al.
Publicado: (2019)

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)

Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer: A meta-analysis
por: Zhang, Yi, et al.
Publicado: (2019)

Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study
por: Fusco, Mario, et al.
Publicado: (2016)

FIB-5 versus FIB-4 index for assessment of hepatic fibrosis in chronic hepatitis B affected patients
por: Metwally, Khaled, et al.
Publicado: (2020)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2017)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2022)

FIB‑4 index and NAFLD fibrosis score are useful indicators for screening high‑risk groups of non‑viral hepatocellular carcinoma
por: Imai, Kenji, et al.
Publicado: (2023)

Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma
por: Wang, Jianlin, et al.
Publicado: (2018)

METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment
por: Wang, Lei, et al.
Publicado: (2023)

TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Cheng, Sheng, et al.
Publicado: (2023)

Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients
por: Li, Xu, et al.
Publicado: (2019)

Pre-treatment prognostic nutritional index may serve as a potential biomarker in urinary cancers: a systematic review and meta-analysis
por: Qi, Feng, et al.
Publicado: (2018)

The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
por: Kim, Minah, et al.
Publicado: (2021)

Prognostic nutritional index before surgical treatment may serve as a prognostic biomarker for patients with upper tract urothelial carcinoma: A systematic review and meta-analysis
por: Meng, Chunyang, et al.
Publicado: (2022)

The Diagnostic Value of the FIB-4 Index for Staging Hepatitis B-Related Fibrosis: A Meta-Analysis
por: Li, Yuanyuan, et al.
Publicado: (2014)

Centromere Protein F (CENPF) Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma
por: Huang, Yugang, et al.
Publicado: (2021)

ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker
por: Xue, Cailin, et al.
Publicado: (2021)

FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma
por: Zhen, Jing, et al.
Publicado: (2023)

APRI and FIB-4 indices as diagnostic noninvasive scores for prediction of severe fibrosis in patients with biliary atresia
por: Nagi, Salma Abdel Megeed, et al.
Publicado: (2023)

FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy
por: Kuwano, Akifumi, et al.
Publicado: (2023)

Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
por: Li, Yijia, et al.
Publicado: (2020)

Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting
por: Blanco-Grau, Albert, et al.
Publicado: (2021)

Development and Validation of a Nomogram Based on Noninvasive Liver Reserve and Fibrosis (PALBI and FIB-4) Model to Predict Posthepatectomy Liver Failure Grade B-C in Patients with Hepatocellular Carcinoma
por: Zhong, Wenhui, et al.
Publicado: (2021)

Noninvasive Identification of Immune-Related Biomarkers in Hepatocellular Carcinoma
por: Li, Ling, et al.
Publicado: (2019)

Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
por: Kim, Seung Up, et al.
Publicado: (2016)

Aberrant Upregulation of 14-3-3σ and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma
por: Zhang, Yi, et al.
Publicado: (2014)

On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma
por: Wang, Hung-Wei, et al.
Publicado: (2020)

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
por: Sumida, Yoshio, et al.
Publicado: (2012)

Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma
por: Li, Limin, et al.
Publicado: (2014)

Six Cell Cycle-related Genes Serve as Potential Prognostic Biomarkers and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
por: Shi, Ying, et al.
Publicado: (2023)

ALBI/ST ratio versus FIB-4 and APRI as a predictor of posthepatectomy liver failure in hepatocellular carcinoma patients
por: Zhang, Ze-Qun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7t58dimbfu9gekubuagcgofrsf